PennyStock101
Long

$OTLK Outlook Therapeutics up 12% premarket, loads more to come.

NASDAQ:OTLK   OUTLOOK THERAPEUTICS INC
This was a real winner yesterday and today is going to be the same, already up 12% pre market, we think there should be continuation in this name for days to come.
Outlook Therapeutics started at outperform with $12 stock price target at Oppenheimer

OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology.
Your Intro To Penny Stock Trading Success...

Sign Up for our 100% Free Email Newsletter:
http://www.PennyStock101.org

Text Message Alerts ---> text 'PS101' to 67076
(It's FREE, however Msg&Data rates may apply.)
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out